Clinical trial
Clinical Investigation on the Effects of Reducing Microalbuminuria in Hypertensive Patients With Type 2 Diabetes - SMART2
NCT01461499 is registered in ClinicalTrials.gov with Shiga University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Investigation on the Effects of Reducing Microalbuminuria in Hypertensive Patients With Type 2 Diabetes - SMART2
- Lead sponsor
- Shiga University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- December 31, 2014
- Enrollment
- 237 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertension, type 2 diabetes mellitus